Olympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth～Strategic Acquisition to Expand its BPH Portfolio into In-office Treatment～
May 28, 2021
Tokyo/Hamburg/Center Valley, May 28, 2021 – Olympus Corporation (”Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has finalized the acquisition of Israeli medical device company Medi-Tate Ltd. (“Medi-Tate” – CEO: Ido Kilemnik) following the announcement of its decision to exercise the call option in February, 2021. Through this acquisition, Olympus expands its business line in offering in-office treatment for benign prostatic hyperplasia (BPH) treatment and solidifies its position as a leader in the field of urological devices.
Information posted on this site is current and accurate only at the time of their original publication date, and may now be outdated or inaccurate.